-
Cost-Effectiveness Analysis of NALIRIFOX as First-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in Japan
Mar 10, 2025, 14:00 PM -
Methodological Approaches and Current Applications of Distributed Cost-Effectiveness Analysis: A Systematic Review
Mar 10, 2025, 14:00 PM -
Developing a Risk Prediction Model for the Identification of Necrotizing Fasciitis (NF) in Patients
Mar 10, 2025, 14:00 PM -
Socioeconomic Evaluation of Breast Cancer Attributable to Benzo[a]pyrene (BaP), Nitrogen Dioxide (NO2), and Polychlorinated Biphenyls 153 (PCB-153) Air Pollutants
Mar 10, 2025, 14:00 PM -
The Impact of Financial Assistance Programs on Medication Adherence: A Systematic Review With AI-Driven Prediction
Mar 10, 2025, 14:00 PM -
Characteristics of Patients Enrolled in a Pharmacist Managed Rare Disease Program: Highlighting National Diversity and Representation
Mar 10, 2025, 14:00 PM -
Parental Self-Efficacy in the Management of Pediatric Type 1 Diabetes Mellitus: A Subgroup Analysis Among CGM Sensor Users
Mar 10, 2025, 14:00 PM -
Comparing the Differences in MentalHealthcare Coverage Between US Public and Private Healthcare Insurers
Mar 10, 2025, 14:00 PM -
Examining The Association Of Self-Reported Condition Severity And Excessive Daytime Sleepiness Severity With Health-Related Outcomes Among Individuals With Narcolepsy In The United States
Mar 10, 2025, 14:00 PM -
Pharmacovigilance Studies Using a Representative Sample From the French National Health Insurance Database (ESND): A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Translation, Cross-Cultural Adaptation and Psychometric Evaluation of the Yoruba Version of Musculoskeletal Health Questionnaire
Mar 10, 2025, 14:00 PM -
Ten-Year Trends in Potentially Inappropriate Sedative-Hypnotics and Pain Medication Use among Medicare Part D Beneficiaries
Mar 10, 2025, 14:00 PM -
The Cost of Managing Postpartum Hemorrhage: An Analysis by a Brazilian Health Insurer
Mar 10, 2025, 14:00 PM -
Increasing Costs of Hospitalizations for Multiple Myeloma in the United States: A Database Analysis on Aggregate Costs and Patient Subpopulations
Mar 10, 2025, 14:00 PM -
Economic Burden of Erythropoietic Protoporphyria (EPP) and X-linked Protoporphyria (XLP): A Large United States (US) Nationwide Claims Analysis
Mar 10, 2025, 14:00 PM -
Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis
Mar 10, 2025, 14:00 PM -
Use of a Representative Sample of the French National Health Insurance Database (ESND) for Research: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Reimbursement Outcomes for EMA Conditionally Authorized Orphan Drugs (2022-2023): Implications for Joint Clinical Assessment Requirements
Mar 10, 2025, 14:00 PM -
Estimating the Prevalence of Chronic Conditions in Population Health Management
Mar 10, 2025, 14:00 PM -
Attitude, Knowledge, and Intention to Receive Shingles Vaccine Using the Theory of Planned Behavior in Saudi Arabia
Mar 10, 2025, 14:00 PM
